Gert van Zyl
Gert van Zyl
Division of Medical Virology, Stellenbosch University and NHLS Tygerberg
Verified email at
Cited by
Cited by
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
MedRxiv, 2020
Detection of a SARS-CoV-2 variant of concern in South Africa
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
Nature 592 (7854), 438-443, 2021
HIV treatment adherence, drug resistance, virologic failure: evolving concepts
J B Nachega, V C Marconi, G U van Zyl, E M Gardner, W Preiser, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2011
Sixteen novel lineages of SARS-CoV-2 in South Africa
H Tegally, E Wilkinson, RJ Lessells, J Giandhari, S Pillay, N Msomi, ...
Nature Medicine 27 (3), 440-446, 2021
Adult antiretroviral therapy guidelines 2017
G Meintjes, MA Moorhouse, S Carmona, N Davies, S Dlamini, ...
Southern African journal of HIV medicine 18 (1), 1-24, 2017
Emergence of HIV drug resistance during first-and second-line antiretroviral therapy in resource-limited settings
MC Hosseinipour, RK Gupta, G Van Zyl, JJ Eron, JB Nachega
The Journal of infectious diseases 207 (suppl_2), S49-S56, 2013
Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting
GU Van Zyl, TE Van Mens, H McIlleron, M Zeier, JB Nachega, E Decloedt, ...
Journal of acquired immune deficiency syndromes (1999) 56 (4), 333, 2011
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy
ET Marinda, J Hargrove, W Preiser, H Slabbert, G Van Zyl, J Levin, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 496-499, 2010
Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein.
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
Nature, 2021
Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection
LG Bekker, K Rebe, F Venter, G Maartens, M Moorhouse, F Conradie, ...
Southern African Journal of HIV Medicine 17 (1), 2016
HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing
SY Rhee, MR Jordan, E Raizes, A Chua, N Parkin, R Kantor, GU Van Zyl, ...
PloS one 10 (12), e0145772, 2015
Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first-and second-line antiretroviral treatment regimens
GU Van Zyl, TF Liu, M Claassen, S Engelbrecht, T De Oliveira, W Preiser, ...
PloS one 8 (6), e67188, 2013
Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen
R Fisher, GU van Zyl, SAA Travers, SL Kosakovsky Pond, S Engelbrech, ...
Journal of virology 86 (11), 6231-6237, 2012
Protease inhibitor resistance in South African children with virologic failure
GU van Zyl, L van der Merwe, M Claassen, MF Cotton, H Rabie, ...
The Pediatric infectious disease journal 28 (12), 1125-1127, 2009
Early Antiretroviral Therapy in South African Children Reduces HIV-1–Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells
GU van Zyl, MA Bedison, AJ van Rensburg, B Laughton, MF Cotton, ...
The Journal of infectious diseases 212 (1), 39-43, 2015
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting
GU Van Zyl, W Preiser, S Potschka, AT Lundershausen, R Haubrich, ...
Clinical Infectious Diseases 52 (2), 264-270, 2011
Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI‐based regimens in the western cape, South Africa
GU van Zyl, L van der Merwe, M Claassen, M Zeier, W Preiser
Journal of medical virology 83 (10), 1764-1769, 2011
No evidence of HIV replication in children on antiretroviral therapy
GU Van Zyl, MG Katusiime, A Wiegand, WR McManus, MJ Bale, ...
The Journal of clinical investigation 127 (10), 3827-3834, 2017
HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high
C Kasang, S Kalluvya, C Majinge, A Stich, J Bodem, G Kongola, ...
PloS one 6 (8), e23091, 2011
HIV evolution and diversity in ART-treated patients
G Van Zyl, MJ Bale, MF Kearney
Retrovirology 15 (1), 1-12, 2018
The system can't perform the operation now. Try again later.
Articles 1–20